Track market-moving stories before they get noisy

Posted by Defense World Staff on Jul 24th, 2026

California Public Employees Retirement System purchased a new position in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 257,133 shares of the biotechnology company’s stock, valued at approximately $16,122,000. California Public Employees Retirement System owned approximately 0.18% of Arrowhead Pharmaceuticals as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Tsfg LLC bought a new position in Arrowhead Pharmaceuticals during the fourth quarter worth about $25,000. iSAM Funds UK Ltd bought a new stake in shares of Arrowhead Pharmaceuticals in the third quarter worth about $29,000. First Horizon Corp bought a new stake in shares of Arrowhead Pharmaceuticals in the fourth quarter worth about $32,000. WPG Advisers LLC raised its position in shares of Arrowhead Pharmaceuticals by 384.8% during the fourth quarter. WPG Advisers LLC now owns 543 shares of the biotechnology company’s stock worth $36,000 after purchasing an additional 431 shares during the period. Finally, Hantz Financial Services Inc. raised its position in shares of Arrowhead Pharmaceuticals by 177.1% during the fourth quarter. Hantz Financial Services Inc. now owns 737 shares of the biotechnology company’s stock worth $49,000 after purchasing an additional 471 shares during the period. Institutional investors and hedge funds own 62.61% of the company’s stock.

Arrowhead Pharmaceuticals Price Performance Shares of ARWR opened at $86.78 on Friday. The stock has a market capitalization of $12.22 billion, a P/E ratio of -40.36 and a beta of 1.26. Arrowhead Pharmaceuticals, Inc. has a twelve month low of $15.01 and a twelve month high of $95.49. The company has a 50 day moving average of $77.76 and a 200-day moving average of $69.86. The company has a quick ratio of 6.23, a current ratio of 6.23 and a debt-to-equity ratio of 1.41.

Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report) last announced its quarterly earnings data on Thursday, May 7th. The biotechnology company reported ($0.93) EPS for the quarter, topping analysts’ consensus estimates of ($1.10) by $0.17. Arrowhead Pharmaceuticals had a negative net margin of 48.38% and a negative return on equity of 55.09%. The business had revenue of $73.74 million for the quarter, compared to analyst estimates of $73.84 million. During the same quarter in the previous year, the firm posted $2.75 earnings per share. The firm’s revenue for the quarter was down 86.4% on a year-over-year basis. As a group, equities research analysts forecast that Arrowhead Pharmaceuticals, Inc. will post -3.09 EPS for the current fiscal year.

Key Arrowhead Pharmaceuticals News Here are the key news stories impacting Arrowhead Pharmaceuticals this week:

Positive Sentiment: Arrowhead reported topline Phase 3 SHASTA-3 and SHASTA-4 results for plozasiran, with both studies meeting the primary endpoint of triglyceride reduction versus placebo; the drug also showed meaningful reductions in acute pancreatitis risk, which investors view as a major de-risking event. Article Title Positive Sentiment: Analysts responded favorably to the data, with Piper Sandler reaffirming an overweight rating and raising its price target to $126, and Morgan Stanley lifting its target to $120, reinforcing expectations for further upside if commercialization progresses. Article Title Positive Sentiment: Coverage highlighted Arrowhead’s stock move to a new 52-week high and described the plozasiran win as a validation of the company’s late-stage pipeline, with some commentary suggesting broader FDA approval and expanded commercialization potential. Article Title Neutral Sentiment: Additional reports noted that Arrowhead’s ARO-033 first-in-human trial showed early safety progress, which is constructive for the pipeline but less immediately important than the plozasiran catalyst. Article Title Negative Sentiment: No major negative company-specific news was provided in the recent items, though one market note flagged that the stock’s valuation has run up sharply, which could make further gains more dependent on execution and regulatory follow-through. Article Title Wall Street Analyst Weigh In A number of research firms recently issued reports on ARWR. Morgan Stanley increased their target price on Arrowhead Pharmaceuticals from $100.00 to $120.00 and gave the stock an “overweight” rating in a research note on Thursday. Wall Street Zen upgraded shares of Arrowhead Pharmaceuticals from a “sell” rating to a “hold” rating in a report on Saturday, June 27th. Sanford C. Bernstein increased their price objective on shares of Arrowhead Pharmaceuticals from $35.00 to $46.00 and gave the stock a “market perform” rating in a research report on Wednesday, May 13th. HC Wainwright restated a “buy” rating and set a $100.00 price objective on shares of Arrowhead Pharmaceuticals in a report on Wednesday, July 1st. Finally, Leerink Partners boosted their price objective on shares of Arrowhead Pharmaceuticals from $61.00 to $72.00 and gave the company a “market perform” rating in a research report on Wednesday, June 17th. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $93.83.

Check Out Our Latest Stock Analysis on ARWR

Insider Transactions at Arrowhead Pharmaceuticals In other Arrowhead Pharmaceuticals news, Director Hongbo Lu sold 2,970 shares of the business’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $76.88, for a total transaction of $228,333.60. Following the sale, the director directly owned 52,012 shares of the company’s stock, valued at $3,998,682.56. The trade was a 5.40% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 3.60% of the company’s stock.

About Arrowhead Pharmaceuticals (Free Report)

Arrowhead Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics. Since its founding in 2008, Arrowhead has leveraged its proprietary delivery platform—known internally as the Advanced RNAi Compound (ARC) technology—to silence disease-causing genes in patients suffering from genetically defined diseases. The company’s approach aims to offer durable, targeted treatments across a range of therapeutic areas.

The company’s pipeline includes multiple candidates in various stages of development.

Featured Articles Five stocks we like better than Arrowhead Pharmaceuticals Premium Retail’s Stress Test Is Separating Winners From Losers D-Wave Quantum or a Quantum ETF: Which Is the Better Bet? GE Vernova Just Sent a Mixed AI Signal to Investors Alphabet Crushed Earnings, But One Number Spooked the Market

Receive News & Ratings for Arrowhead Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arrowhead Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINECalifornia Public Employees Retirement System Grows Stock Holdings in AGNC Investment Corp. $AGNC

NEXT HEADLINE »Enersys $ENS Shares Purchased by California Public Employees Retirement System

California Public Employees Retirement System cut its holdings in shares of Toast, Inc. (NYSE: TOST) by 20.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 671,880 shares of the company's stock after selling 177,043 shares during the quarter. California

Generální ředitel JPMorgan Chase Jamie Dimon se domnívá, že finanční trhy neberou dostatečně vážně řadu rizik, která mohou v dalších letech dopadnout na globální ekonomiku. V rozhovoru pro server CNBC uvedl, že by za současných podmínek nekupoval ani široký akciový trh, ani dlouhodobé americké státní dluhopisy.

Podle šéfa největší americké banky zůstávají investoři až příliš klidní navzdory rostoucímu počtu geopolitických hrozeb. Jako hlavní rizikové faktory zmínil pokračující konflikty na Ukrajině a na Blízkém východě, zhoršené vztahy mezi Spojenými státy a Čínou nebo rostoucí výdaje na obranu v prostředí vysokého zadlužení vlád.

„Myslím, že tato rizika jsou pravděpodobně větší, než si ostatní myslí,“ prohlásil Dimon, který je dlouhodobě známý tím, že veřejnost často varuje před ekonomickými riziky, a dodal, že právě rozsah a důsledky takových událostí podle něj investoři často podceňují.

Jeho současný opatrný pohled kontrastuje s vývojem na trzích v posledních měsících. Americké akcie letos výrazně posílily, spotřebitelská poptávka je odolná, inflace je na ústupu a nadšení kolem investic spojených s umělou inteligencí nezná konce.

Bankovní sektor navíc nedávno reportoval velmi silné hospodářské výsledky, což podpořilo přesvědčení části investorů, že americká ekonomika dokáže geopolitickým otřesům odolávat lépe, než se očekávalo, píše server CNBC.

Významnou hrozbou zůstávají podle Dimona dlouhodobé rozpočtové deficity Spojených států. „Můj názor je takový, že se z toho stane problém,“ řekl v podcastu a předpověděl vyšší úrokové sazby, protože investoři budou požadovat větší kompenzaci za financování amerického dluhu.

V této souvislosti připomněl roli takzvaných „bond vigilantes“, tedy investorů, kteří prostřednictvím prodeje dluhopisů vytvářejí tlak na růst výnosů v případě obav o fiskální stabilitu.

Právě proto není příznivcem dlouhodobých amerických státních dluhopisů. I kdyby se inflace vrátila k dvouprocentnímu cíli Fedu, tak desetiletý americký výnos by se podle něj měl pohybovat přibližně mezi čtyřmi a 4,5 procenty. Prostor pro další růst cen dluhopisů tak vnímá jako omezený.

Vybrané tituly jsou skvělou příležitostí

Stejnou zdrženlivost projevuje i vůči akciovému trhu jako celku. Zatímco konkrétní jednotlivé tituly mohou podle něj stále představovat „skvělou investiční příležitost“, tak současné ocenění širšího trhu nepovažuje za dostatečně atraktivní, aby jej motivovalo k nákupu.

V rozhovoru se samozřejmě dotkl také fenoménu umělé inteligence. Současnou investiční vlnu přirovnal k internetovému boomu z přelomu tisíciletí. Obrovské objemy kapitálu, které dnes do AI směřují, podle něj pravděpodobně povedou k významným technologickým změnám podobně jako kdysi při nástupu internetu.

Cesta k vítězům ovšem nemusí být přímočará. Jako příklad uvedl, že v internetové éře spousta tehdejších hvězd jako Yahoo nebo Netscape nakonec ztratila význam, zatímco dominantní hráči (Google, Facebook) vznikli až později. Proto nelze automaticky předpokládat, že současní lídři budou zároveň největšími vítězi AI revoluce, uzavřel Dimon.

USD/MXN sits at 17.47988, drifting sideways within the shaded 17.50 zone. Source: TradingView The US dollar has drifted a little bit lower against the Mexican peso, and while the interest rates in America are fairly high by historical standards, traders still get paid to hold pesos, not dollars here. So, this, too, is following the interest rate differential path. The 50-day EMA is right at the 17.43 level, and of course, we’ve seen some sideways action between 17.35 and 17.60 over the last several weeks.

Looks like more of the same here. 17.50 seems to be a little bit of a magnet for price, but ultimately this is a market that’s just trying to figure out what to do longer term. This pair does get to be choppy for a while. This is part of the reason why these pairs attract so many inflows at times to use for that overall interest rate differential payment at the end of the day. Right now, though, there are so many questions involving the Middle East, the global economy, and everything else; it’s not a surprise that we’re somewhat stagnant.

Posted by Defense World Staff on Jul 24th, 2026

Andra AP fonden lessened its holdings in Teledyne Technologies Incorporated (NYSE:TDY – Free Report) by 88.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,320 shares of the scientific and technical instruments company’s stock after selling 9,780 shares during the period. Andra AP fonden’s holdings in Teledyne Technologies were worth $799,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Meeder Asset Management Inc. acquired a new position in shares of Teledyne Technologies in the first quarter valued at approximately $27,000. Thurston Springer Miller Herd & Titak Inc. bought a new stake in Teledyne Technologies during the fourth quarter valued at $28,000. DV Equities LLC acquired a new stake in Teledyne Technologies during the fourth quarter worth approximately $33,000. Banque Cantonale Vaudoise acquired a new stake in shares of Teledyne Technologies during the 3rd quarter worth approximately $43,000. Finally, eCIO Inc. bought a new stake in Teledyne Technologies in the fourth quarter valued at $47,000. Institutional investors own 91.58% of the company’s stock.

Teledyne Technologies Trading Up 0.1% NYSE:TDY opened at $650.87 on Friday. The company has a current ratio of 2.18, a quick ratio of 1.16 and a debt-to-equity ratio of 0.19. The stock has a market capitalization of $30.15 billion, a PE ratio of 31.43, a price-to-earnings-growth ratio of 3.05 and a beta of 0.92. The firm’s 50 day moving average is $627.09 and its 200 day moving average is $629.20. Teledyne Technologies Incorporated has a 12 month low of $483.02 and a 12 month high of $693.38.

Teledyne Technologies (NYSE:TDY – Get Free Report) last announced its quarterly earnings data on Wednesday, July 22nd. The scientific and technical instruments company reported $6.28 earnings per share for the quarter, beating the consensus estimate of $5.79 by $0.49. Teledyne Technologies had a return on equity of 10.56% and a net margin of 15.29%.The business had revenue of $1.66 billion during the quarter, compared to analyst estimates of $1.58 billion. During the same period in the prior year, the company earned $5.20 earnings per share. Teledyne Technologies’s revenue was up 9.8% compared to the same quarter last year. Teledyne Technologies has set its FY 2026 guidance at 24.450-24.650 EPS and its Q3 2026 guidance at 6.050-6.150 EPS. Sell-side analysts expect that Teledyne Technologies Incorporated will post 24.55 earnings per share for the current year.

Analyst Upgrades and Downgrades Several equities analysts have recently weighed in on TDY shares. Needham & Company LLC upped their price objective on shares of Teledyne Technologies from $735.00 to $750.00 and gave the company a “buy” rating in a report on Thursday. Jefferies Financial Group raised Teledyne Technologies to a “strong-buy” rating in a research report on Wednesday, June 10th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Teledyne Technologies in a research note on Friday, May 22nd. Barclays boosted their price objective on Teledyne Technologies from $603.00 to $614.00 and gave the company an “equal weight” rating in a report on Friday, April 24th. Finally, Stifel Nicolaus upped their target price on Teledyne Technologies from $750.00 to $775.00 and gave the stock a “buy” rating in a research report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $711.50.

View Our Latest Stock Analysis on TDY

Teledyne Technologies News Roundup Here are the key news stories impacting Teledyne Technologies this week:

Positive Sentiment: Teledyne reported better-than-expected Q2 results, with non-GAAP EPS of $6.28 versus estimates near $5.79 and revenue of $1.66 billion versus $1.58 billion expected, helped by broad-based sales growth and record orders. Teledyne Technologies Reports Second Quarter Results Positive Sentiment: The company raised full-year 2026 EPS guidance to $24.45-$24.65 and Q3 guidance to $6.05-$6.15, both above consensus, signaling management expects momentum to continue. Teledyne Technologies Reports Second Quarter Results Positive Sentiment: Several analysts responded by lifting price targets and reiterating buy ratings, including Stifel to $775 and Needham to $750, suggesting Wall Street sees more upside after the earnings beat. Benzinga analyst updates Positive Sentiment: Teledyne also announced a five-year partnership with the RNLI to provide navigation and thermal imaging technology, a modestly positive contract win that supports its marine and sensing businesses. RNLI partnership announcement Neutral Sentiment: Some commentary notes the stock is trading at a premium valuation after the rally, which may limit near-term upside even as fundamentals improve. Teledyne (TDY) Stock Trades At A Premium To Fair Value Teledyne Technologies Company Profile (Free Report)

Teledyne Technologies (NYSE: TDY), headquartered in Thousand Oaks, California, is a diversified industrial technology company that designs, manufactures and supports sophisticated electronic systems, instruments and imaging products. Founded in 1960 by Henry Singleton and George Kozmetsky, Teledyne has grown into a multinational provider of high-performance equipment and software for commercial, scientific and government customers. Its offerings are used in markets that include aerospace and defense, marine, industrial manufacturing, environmental monitoring and scientific research.

The company operates through businesses that develop precision instrumentation, digital imaging products, engineered systems and aerospace and defense electronics.

See Also Five stocks we like better than Teledyne Technologies Premium Retail’s Stress Test Is Separating Winners From Losers D-Wave Quantum or a Quantum ETF: Which Is the Better Bet? GE Vernova Just Sent a Mixed AI Signal to Investors Alphabet Crushed Earnings, But One Number Spooked the Market

Receive News & Ratings for Teledyne Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teledyne Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEPromising Streaming Stocks To Follow Today – July 22nd

NEXT HEADLINE »Amazon.com, Inc. $AMZN Shares Acquired by Ferguson Wellman Capital Management Inc.

Posted by Defense World Staff on Jul 24th, 2026

California Public Employees Retirement System lifted its holdings in shares of Watts Water Technologies, Inc. (NYSE:WTS – Free Report) by 12.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 60,311 shares of the technology company’s stock after acquiring an additional 6,718 shares during the period. California Public Employees Retirement System owned 0.18% of Watts Water Technologies worth $17,508,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Future Fund LLC raised its position in Watts Water Technologies by 26.1% in the 1st quarter. Future Fund LLC now owns 9,438 shares of the technology company’s stock valued at $2,740,000 after purchasing an additional 1,953 shares during the last quarter. Assetmark Inc. boosted its stake in Watts Water Technologies by 211.3% during the 1st quarter. Assetmark Inc. now owns 165 shares of the technology company’s stock worth $48,000 after purchasing an additional 112 shares during the period. Illinois Municipal Retirement Fund grew its position in Watts Water Technologies by 12.0% during the 1st quarter. Illinois Municipal Retirement Fund now owns 13,134 shares of the technology company’s stock worth $3,813,000 after purchasing an additional 1,404 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt grew its position in Watts Water Technologies by 20,071.4% during the 1st quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 141,200 shares of the technology company’s stock worth $40,989,000 after purchasing an additional 140,500 shares during the last quarter. Finally, Nwam LLC acquired a new position in Watts Water Technologies in the first quarter valued at $206,000. 95.02% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes A number of equities research analysts have recently commented on the stock. Royal Bank Of Canada upped their target price on shares of Watts Water Technologies from $323.00 to $350.00 and gave the company a “sector perform” rating in a report on Thursday, July 16th. Barclays raised Watts Water Technologies from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $317.00 to $414.00 in a report on Tuesday, June 30th. TD Cowen boosted their price target on Watts Water Technologies from $275.00 to $320.00 and gave the company a “hold” rating in a research report on Thursday, July 2nd. Weiss Ratings downgraded Watts Water Technologies from a “buy (b+)” rating to a “buy (b)” rating in a research note on Monday, May 11th. Finally, Robert W. Baird set a $330.00 price objective on Watts Water Technologies in a research report on Friday, May 8th. Five investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $345.30.

Check Out Our Latest Stock Report on Watts Water Technologies

Watts Water Technologies Stock Performance Shares of WTS opened at $342.90 on Friday. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.62 and a current ratio of 2.72. The stock has a market capitalization of $11.45 billion, a P/E ratio of 31.37, a P/E/G ratio of 2.95 and a beta of 1.14. The company’s fifty day moving average is $334.96 and its two-hundred day moving average is $314.35. Watts Water Technologies, Inc. has a 1 year low of $249.06 and a 1 year high of $394.54.

Watts Water Technologies (NYSE:WTS – Get Free Report) last released its earnings results on Wednesday, May 6th. The technology company reported $3.04 EPS for the quarter, topping the consensus estimate of $2.72 by $0.32. The company had revenue of $677.30 million during the quarter, compared to analysts’ expectations of $638.13 million. Watts Water Technologies had a net margin of 14.32% and a return on equity of 18.92%. The business’s revenue was up 21.4% on a year-over-year basis. During the same quarter last year, the business earned $2.37 EPS. On average, sell-side analysts predict that Watts Water Technologies, Inc. will post 12.23 earnings per share for the current year.

Watts Water Technologies Announces Dividend The company also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were given a $0.63 dividend. The ex-dividend date was Monday, June 1st. This represents a $2.52 dividend on an annualized basis and a yield of 0.7%. Watts Water Technologies’s dividend payout ratio (DPR) is presently 23.06%.

Insider Transactions at Watts Water Technologies In other news, Director Michael J. Dubose sold 398 shares of the stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $309.63, for a total transaction of $123,232.74. Following the completion of the transaction, the director directly owned 1,814 shares of the company’s stock, valued at approximately $561,668.82. This represents a 17.99% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Elie Melhem sold 2,257 shares of the stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of $301.00, for a total value of $679,357.00. Following the transaction, the insider directly owned 8,963 shares of the company’s stock, valued at approximately $2,697,863. This trade represents a 20.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 1.00% of the stock is owned by company insiders.

Watts Water Technologies Profile (Free Report)

Watts Water Technologies, Inc is a global manufacturer and distributor of flow control products and solutions designed to ensure the safe, efficient delivery and use of water. Founded in 1874 and headquartered in North Andover, Massachusetts, the company has built a reputation for engineering innovation in residential, commercial and industrial plumbing, heating, cooling and water treatment systems. Watts operates through a comprehensive portfolio of brands and product lines that address application-specific requirements in water safety, pressure regulation, flow control and filtration.

The company’s product offerings span backflow preventers, pressure reducing valves, relief valves and steam traps, as well as hydronic balancing and temperature control devices for heating systems.

Read More Five stocks we like better than Watts Water Technologies Premium Retail’s Stress Test Is Separating Winners From Losers D-Wave Quantum or a Quantum ETF: Which Is the Better Bet? GE Vernova Just Sent a Mixed AI Signal to Investors Alphabet Crushed Earnings, But One Number Spooked the Market Want to see what other hedge funds are holding WTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Watts Water Technologies, Inc. (NYSE:WTS – Free Report).

Receive News & Ratings for Watts Water Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Watts Water Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEEnersys $ENS Shares Purchased by California Public Employees Retirement System

Posted by Defense World Staff on Jul 24th, 2026

Bank of Nova Scotia lessened its stake in shares of Arista Networks, Inc. (NYSE:ANET – Free Report) by 1.6% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 857,037 shares of the technology company’s stock after selling 14,176 shares during the period. Bank of Nova Scotia owned 0.07% of Arista Networks worth $105,230,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of the company. Lighthouse Financial Services Inc. ADV acquired a new stake in shares of Arista Networks in the fourth quarter valued at about $1,549,000. Bensler LLC bought a new position in shares of Arista Networks during the fourth quarter worth about $6,350,000. QRG Capital Management Inc. lifted its stake in shares of Arista Networks by 6.4% in the fourth quarter. QRG Capital Management Inc. now owns 169,613 shares of the technology company’s stock worth $22,224,000 after acquiring an additional 10,217 shares during the period. Jefferies Financial Group Inc. lifted its stake in shares of Arista Networks by 59.8% in the fourth quarter. Jefferies Financial Group Inc. now owns 17,621 shares of the technology company’s stock worth $2,309,000 after acquiring an additional 6,591 shares during the period. Finally, Reaves W H & Co. Inc. bought a new stake in Arista Networks in the fourth quarter valued at approximately $3,058,000. 82.47% of the stock is currently owned by institutional investors and hedge funds.

Arista Networks Stock Up 0.9% Shares of ANET stock opened at $176.53 on Friday. The firm has a 50 day moving average of $164.31 and a 200-day moving average of $148.52. The company has a market cap of $222.29 billion, a price-to-earnings ratio of 60.46, a price-to-earnings-growth ratio of 2.68 and a beta of 1.60. Arista Networks, Inc. has a 52 week low of $112.80 and a 52 week high of $189.82.

Arista Networks (NYSE:ANET – Get Free Report) last issued its earnings results on Tuesday, May 5th. The technology company reported $0.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.81 by $0.06. The business had revenue of $2.71 billion for the quarter, compared to analyst estimates of $2.62 billion. Arista Networks had a net margin of 38.32% and a return on equity of 30.10%. Arista Networks’s revenue was up 35.1% on a year-over-year basis. During the same period in the prior year, the firm earned $0.65 earnings per share. Arista Networks has set its Q2 2026 guidance at 0.880-0.880 EPS. Analysts anticipate that Arista Networks, Inc. will post 3.28 earnings per share for the current year.

Insider Activity In related news, major shareholder Andreas Bechtolsheim sold 260,000 shares of the business’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $165.57, for a total value of $43,048,200.00. Following the completion of the sale, the insider directly owned 182,543,048 shares of the company’s stock, valued at $30,223,652,457.36. The trade was a 0.14% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Kenneth Duda sold 32,000 shares of the company’s stock in a transaction that occurred on Monday, May 18th. The stock was sold at an average price of $140.08, for a total value of $4,482,560.00. Following the transaction, the insider directly owned 12,976 shares in the company, valued at approximately $1,817,678.08. This trade represents a 71.15% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 2,264,983 shares of company stock worth $376,175,065. Company insiders own 2.70% of the company’s stock.

Key Stories Impacting Arista Networks Here are the key news stories impacting Arista Networks this week:

Positive Sentiment: Needham raised its price target on Arista Networks to $200 and maintained a Buy rating, signaling confidence in continued upside for the AI networking leader. Positive Sentiment: Multiple recent articles highlight Arista as a beneficiary of expanding AI adoption, which supports the investment case for its data-center and enterprise networking products. Positive Sentiment: Coverage also pointed to Arista’s new AI-driven VeloCloud security solution and AI zero-trust branch platform, both of which could help expand enterprise demand and deepen its product mix. Article Title Positive Sentiment: Some commentary says Arista is still benefiting from strong 2026 momentum and may have more room to run after a strong first half of the year. Article Title Neutral Sentiment: One valuation-focused piece argued the stock looks fairly priced by discounted cash flow but expensive on traditional multiples, creating a mixed picture for investors. Article Title Neutral Sentiment: Several other items were largely commentary or ranking pieces that reinforce Arista’s growth reputation but do not introduce a major new catalyst. Article Title Analyst Upgrades and Downgrades A number of analysts have weighed in on the stock. KeyCorp reissued an “overweight” rating and set a $200.00 target price (up from $178.00) on shares of Arista Networks in a research report on Thursday, June 18th. Erste Group Bank upgraded shares of Arista Networks from a “hold” rating to a “buy” rating in a research report on Wednesday, July 15th. Citigroup reduced their price objective on shares of Arista Networks from $176.00 to $173.00 and set a “buy” rating on the stock in a research note on Wednesday, May 6th. JPMorgan Chase & Co. lifted their target price on shares of Arista Networks from $190.00 to $200.00 and gave the stock an “overweight” rating in a research note on Thursday, April 16th. Finally, Bank of America boosted their target price on shares of Arista Networks from $185.00 to $200.00 and gave the company a “buy” rating in a report on Monday, June 8th. Two research analysts have rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $189.74.

Read Our Latest Analysis on ANET

Arista Networks Company Profile (Free Report)

Arista Networks, Inc is a technology company that designs and sells cloud networking solutions for large-scale data centers and enterprise environments. The company is best known for its high-performance switching and routing platforms, which are used to build scalable, low-latency networks for cloud service providers, internet companies, financial services, telecommunications, and enterprise IT. Arista’s offerings emphasize programmability, automation and telemetry to support modern, software-driven network architectures.

Central to Arista’s product portfolio is its Extensible Operating System (EOS), a modular network operating system that provides consistent programmability, stateful control and advanced visibility across the company’s hardware platforms.

See Also Five stocks we like better than Arista Networks Premium Retail’s Stress Test Is Separating Winners From Losers D-Wave Quantum or a Quantum ETF: Which Is the Better Bet? GE Vernova Just Sent a Mixed AI Signal to Investors Alphabet Crushed Earnings, But One Number Spooked the Market

Receive News & Ratings for Arista Networks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arista Networks and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBank of Nova Scotia Has $89.08 Million Holdings in Halliburton Company $HAL

NEXT HEADLINE »Bessemer Group Inc. Has $1.26 Million Holdings in Elevance Health, Inc. $ELV

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In AeroVironment To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in AeroVironment between 4:30 PM EST on June 24, 2025 and June 18, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

[You may also click here for additional information]

New York, New York--(Newsfile Corp. - July 24, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against AeroVironment, Inc. ("AeroVironment" or the "Company") (NASDAQ: AVAV) and reminds investors of the July 27, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) AeroVironment understated the likelihood that it would imminently face competition from other vendors for the work it performed in connection with the SCAR program and the U.S. Space Force's ongoing efforts to modernize the SCN; (2) accordingly, Defendants overstated AeroVironment's business and financial prospects; and (3) as a result, Defendants' public statements were materially false and misleading at all relevant times.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding AeroVironment's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the AeroVironment class action, go to www.faruqilaw.com/AVAV or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Frequently Asked Questions (FAQ) for Investors Regarding the AeroVironment Securities Class Action Lawsuit:

What is the AeroVironment securities fraud lawsuit about?

The AeroVironment securities fraud lawsuit is a federal securities class action alleging that AeroVironment, Inc. (NASDAQ: AVAV) and its executives made false and misleading statements to investors by concealing that the Company faced imminent competition for its SCAR program contracts and overstating its business and financial prospects. As the truth emerged through a series of disclosures — including a U.S. government stop work order on January 20, 2026, a Space Force announcement that it was reopening the SCAR program on March 2, 2026, and AeroVironment's disclosure of a $151.3 million goodwill impairment and contract termination on March 10, 2026 — AVAV's stock price dropped sharply, causing significant losses for investors.

Who may be eligible to participate in the lawsuit?

Investors who purchased or acquired AeroVironment (AVAV) stock between 4:30 PM EST on June 24, 2025 and June 18, 2026 — the Class Period — and suffered financial losses may be eligible to participate in the AeroVironment securities class action. Participation as a class member does not require taking any affirmative legal action; eligible investors may recover losses simply by remaining members of the class. Whistleblowers, former AeroVironment employees, and others with relevant information about the Company's conduct are also encouraged to come forward.

What is a lead plaintiff, and how can I seek appointment?

A lead plaintiff in the AeroVironment class action is a court-appointed investor — typically the one with the largest financial interest in the case — who directs and oversees the litigation on behalf of all class members. Any AeroVironment investor who purchased AVAV stock during the Class Period may move the Court to serve as lead plaintiff through counsel of their choice. The deadline to seek lead plaintiff appointment is July 27, 2026. Importantly, choosing not to seek the lead plaintiff role does not affect an investor's ability to share in any recovery obtained for the class.

What should investors do if they purchased AeroVironment stock during the Class Period?

Investors who purchased AeroVironment (AVAV) stock between 4:30 PM EST on June 24, 2025 and June 18, 2026 and suffered losses should contact Faruqi & Faruqi, LLP immediately to discuss their legal rights. The deadline to seek appointment as lead plaintiff in the AeroVironment securities class action is July 27, 2026. To speak directly with securities litigation partner Josh Wilson, call 877-247-4292 or 212-983-9330 (Ext. 1310), or visit www.faruqilaw.com/AVAV for more information.

Why should investors contact Faruqi & Faruqi, LLP?

Faruqi & Faruqi, LLP has represented investors in securities litigation for decades and has recovered hundreds of millions of dollars for shareholders. Investors who purchased AeroVironment securities during the Class Period may contact the firm to discuss their legal rights, potential claims, and the lead plaintiff process at no cost or obligation.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/306304

Source: Faruqi & Faruqi LLP

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Posted by Defense World Staff on Jul 24th, 2026

California Public Employees Retirement System lowered its position in NewJersey Resources Corporation (NYSE:NJR – Free Report) by 5.2% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 275,561 shares of the utilities provider’s stock after selling 15,072 shares during the period. California Public Employees Retirement System owned approximately 0.27% of NewJersey Resources worth $15,134,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in NewJersey Resources by 6.1% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 59,363 shares of the utilities provider’s stock valued at $2,912,000 after purchasing an additional 3,422 shares during the last quarter. NewEdge Advisors LLC increased its position in shares of NewJersey Resources by 65.7% in the first quarter. NewEdge Advisors LLC now owns 22,214 shares of the utilities provider’s stock valued at $1,090,000 after buying an additional 8,808 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of NewJersey Resources by 10.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 320,113 shares of the utilities provider’s stock worth $15,705,000 after buying an additional 29,458 shares during the last quarter. Jane Street Group LLC acquired a new position in shares of NewJersey Resources during the 1st quarter worth $8,907,000. Finally, Invesco Ltd. boosted its position in shares of NewJersey Resources by 14.4% in the 2nd quarter. Invesco Ltd. now owns 465,923 shares of the utilities provider’s stock worth $20,883,000 after buying an additional 58,795 shares in the last quarter. 70.98% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at NewJersey Resources In other news, COO Patrick J. Migliaccio sold 3,000 shares of the stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $55.84, for a total transaction of $167,520.00. Following the transaction, the chief operating officer owned 35,202 shares of the company’s stock, valued at approximately $1,965,679.68. This trade represents a 7.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Jane M. Kenny sold 8,000 shares of NewJersey Resources stock in a transaction on Friday, May 8th. The stock was sold at an average price of $56.10, for a total transaction of $448,800.00. Following the completion of the transaction, the director directly owned 21,998 shares of the company’s stock, valued at approximately $1,234,087.80. This represents a 26.67% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 12,150 shares of company stock valued at $682,261. Insiders own 0.70% of the company’s stock.

NewJersey Resources Stock Performance Shares of NJR stock opened at $59.38 on Friday. The company has a debt-to-equity ratio of 1.24, a quick ratio of 0.80 and a current ratio of 0.94. The firm has a market capitalization of $5.99 billion, a price-to-earnings ratio of 17.62 and a beta of 0.50. NewJersey Resources Corporation has a one year low of $43.46 and a one year high of $60.69. The company has a 50 day moving average price of $56.60 and a 200 day moving average price of $54.37.

NewJersey Resources (NYSE:NJR – Get Free Report) last announced its quarterly earnings results on Monday, May 4th. The utilities provider reported $2.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.89 by $0.31. NewJersey Resources had a return on equity of 14.58% and a net margin of 15.67%.The firm had revenue of $939.40 million during the quarter, compared to the consensus estimate of $849.95 million. During the same period in the prior year, the firm earned $1.78 EPS. The firm’s quarterly revenue was up 2.9% compared to the same quarter last year. NewJersey Resources has set its FY 2026 guidance at 3.480-3.630 EPS. Sell-side analysts anticipate that NewJersey Resources Corporation will post 3.58 EPS for the current year.

Wall Street Analyst Weigh In A number of brokerages have recently weighed in on NJR. Weiss Ratings raised shares of NewJersey Resources from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday, May 27th. Wells Fargo & Company assumed coverage on NewJersey Resources in a research note on Tuesday, May 12th. They issued an “overweight” rating and a $63.00 target price on the stock. Argus set a $63.00 target price on NewJersey Resources in a report on Wednesday, May 20th. Finally, Mizuho boosted their price target on NewJersey Resources from $54.00 to $61.00 and gave the stock an “outperform” rating in a report on Tuesday, April 21st. Two investment analysts have rated the stock with a Strong Buy rating and three have issued a Buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $58.17.

Check Out Our Latest Report on NewJersey Resources

NewJersey Resources Company Profile (Free Report)

New Jersey Resources Corporation is a publicly traded energy services holding company headquartered in Wall Township, New Jersey. The firm’s primary focus is on the safe and reliable distribution of natural gas, along with complementary energy services and renewable energy investments. Its operations center on delivering cost-effective solutions to residential, commercial and industrial customers throughout the state.

The company’s principal subsidiary, New Jersey Natural Gas, owns and operates an extensive pipeline network that spans northern, central and southern New Jersey.

Featured Stories Five stocks we like better than NewJersey Resources Premium Retail’s Stress Test Is Separating Winners From Losers D-Wave Quantum or a Quantum ETF: Which Is the Better Bet? GE Vernova Just Sent a Mixed AI Signal to Investors Alphabet Crushed Earnings, But One Number Spooked the Market Want to see what other hedge funds are holding NJR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NewJersey Resources Corporation (NYSE:NJR – Free Report).

Receive News & Ratings for NewJersey Resources Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NewJersey Resources and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEDimensional Fund Advisors LP Purchases 3,291,431 Shares of Coeur Mining, Inc. $CDE

NEXT HEADLINE »California Public Employees Retirement System Has $16.55 Million Position in Guidewire Software, Inc. $GWRE

Orbex Group Limited is the holding company of Orbex Global Limited, Orbex Limited is an affiliate with Orbex Global Limited. Orbex Global Limited is authorized and regulated by Mauritius Financial Services Commission “FSC” (View License). Orbex.com is owned by Orbex Group Limited and is operated by Orbex Global Limited with registered address: Ground Floor, The Catalyst, Silicon Avenue, 40 Cybercity, 72201 Ebène, Republic of Mauritius

Risk Warning: Trading foreign exchange on margin carries a high level of risk, and may not be suitable for all investors. Before deciding to trade foreign exchange, you should carefully consider your investment objectives, level of experience, and risk appetite. There is a possibility that you may sustain a loss of some or all of your investment and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with foreign exchange trading, and seek advice from an independent financial advisor if you have any doubts. Orbex Global does not offer its services to residents of certain jurisdictions such as Mauritius, USA, and North Korea.

Orbex Group Limited is the holding company of Orbex Global Limited, Orbex Limited is an affiliate with Orbex Global Limited. Orbex Global Limited is authorized and regulated by Mauritius Financial Services Commission “FSC” (View License). Orbex.com is owned by Orbex Group Limited and is operated by Orbex Global Limited with registered address: Ground Floor, The Catalyst, Silicon Avenue, 40 Cybercity, 72201 Ebène, Republic of Mauritius

Risk Warning: Trading foreign exchange on margin carries a high level of risk, and may not be suitable for all investors. Before deciding to trade foreign exchange, you should carefully consider your investment objectives, level of experience, and risk appetite. There is a possibility that you may sustain a loss of some or all of your investment and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with foreign exchange trading, and seek advice from an independent financial advisor if you have any doubts. Orbex Global does not offer its services to residents of certain jurisdictions such as Mauritius, USA, and North Korea.

Posted by Defense World Staff on Jul 24th, 2026

Bessemer Group Inc. decreased its stake in shares of Corpay, Inc (NYSE:CPAY – Free Report) by 28.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,900 shares of the corporate payments company’s stock after selling 1,560 shares during the period. Bessemer Group Inc.’s holdings in Corpay were worth $1,135,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CPAY. MV Capital Management Inc. purchased a new position in shares of Corpay in the 4th quarter worth $25,000. Leonteq Securities AG bought a new position in Corpay in the fourth quarter valued at about $27,000. BOKF NA lifted its holdings in Corpay by 4,700.0% in the third quarter. BOKF NA now owns 96 shares of the corporate payments company’s stock valued at $28,000 after acquiring an additional 94 shares during the period. Torren Management LLC purchased a new position in Corpay in the fourth quarter worth about $29,000. Finally, DV Equities LLC purchased a new position in Corpay in the fourth quarter worth about $30,000. Hedge funds and other institutional investors own 98.84% of the company’s stock.

Insider Buying and Selling In other Corpay news, Director Steven T. Stull sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $360.78, for a total value of $360,780.00. Following the completion of the transaction, the director directly owned 28,241 shares in the company, valued at $10,188,787.98. This represents a 3.42% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Armando Lins Netto sold 70,476 shares of the stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $352.13, for a total transaction of $24,816,713.88. Following the sale, the insider directly owned 11,274 shares of the company’s stock, valued at approximately $3,969,913.62. This trade represents a 86.21% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 88,677 shares of company stock worth $31,304,091. 5.19% of the stock is owned by insiders.

Wall Street Analyst Weigh In Several research firms have recently commented on CPAY. Morgan Stanley reaffirmed an “overweight” rating and set a $400.00 price target on shares of Corpay in a research report on Sunday, May 10th. Wolfe Research reissued an “outperform” rating and set a $450.00 price objective on shares of Corpay in a research report on Wednesday, June 3rd. Loop Capital assumed coverage on Corpay in a research report on Monday, May 18th. They set a “buy” rating and a $406.00 target price on the stock. Robert W. Baird cut their price target on Corpay from $440.00 to $380.00 and set an “outperform” rating for the company in a report on Tuesday, March 31st. Finally, Oppenheimer restated an “outperform” rating and issued a $388.00 price target on shares of Corpay in a research report on Friday, May 8th. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Corpay presently has an average rating of “Moderate Buy” and a consensus target price of $382.54.

Read Our Latest Report on CPAY

Corpay Stock Up 1.6% Shares of CPAY stock opened at $364.63 on Friday. The company has a debt-to-equity ratio of 1.86, a current ratio of 0.98 and a quick ratio of 0.98. Corpay, Inc has a one year low of $252.84 and a one year high of $374.09. The company’s fifty day moving average price is $350.25 and its 200-day moving average price is $333.33. The company has a market capitalization of $23.83 billion, a price-to-earnings ratio of 21.82, a PEG ratio of 0.98 and a beta of 0.88.

Corpay (NYSE:CPAY – Get Free Report) last posted its quarterly earnings results on Thursday, May 14th. The corporate payments company reported ($0.01) EPS for the quarter. Corpay had a net margin of 24.60% and a return on equity of 38.68%. The business had revenue of $5.63 million for the quarter. Sell-side analysts expect that Corpay, Inc will post 25.49 EPS for the current fiscal year.

Corpay Company Profile (Free Report)

Corpay is a global corporate payments company that provides businesses with a range of payment and expense management solutions. Its services are designed to help organizations manage payables, card programs, travel and fleet-related expenses, and cross-border transactions more efficiently.

The company serves customers across a variety of industries and geographies, offering software and payment tools that streamline accounts payable, vendor payments, and workforce payments. Corpay also provides specialized solutions for fleet management and international payments, helping businesses control costs and simplify financial operations.

Corpay operates as part of the broader financial technology and payment processing sector.

Read More Five stocks we like better than Corpay Premium Retail’s Stress Test Is Separating Winners From Losers D-Wave Quantum or a Quantum ETF: Which Is the Better Bet? GE Vernova Just Sent a Mixed AI Signal to Investors Alphabet Crushed Earnings, But One Number Spooked the Market

Receive News & Ratings for Corpay Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corpay and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBessemer Group Inc. Sells 9,510 Shares of AAON, Inc. $AAON

Posted by Defense World Staff on Jul 24th, 2026

Assetmark Inc. reduced its stake in shares of Hyatt Hotels Corporation (NYSE:H – Free Report) by 76.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,963 shares of the company’s stock after selling 60,707 shares during the period. Assetmark Inc.’s holdings in Hyatt Hotels were worth $2,727,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Johnson Financial Group Inc. raised its stake in Hyatt Hotels by 450.0% in the 3rd quarter. Johnson Financial Group Inc. now owns 176 shares of the company’s stock valued at $25,000 after purchasing an additional 144 shares during the last quarter. Los Angeles Capital Management LLC acquired a new stake in shares of Hyatt Hotels during the 4th quarter worth about $26,000. DV Equities LLC purchased a new stake in shares of Hyatt Hotels during the fourth quarter worth about $32,000. Ares Financial Consulting LLC purchased a new position in shares of Hyatt Hotels during the fourth quarter valued at approximately $34,000. Finally, Measured Wealth Private Client Group LLC acquired a new stake in Hyatt Hotels during the third quarter worth approximately $34,000. Institutional investors and hedge funds own 73.54% of the company’s stock.

Insider Buying and Selling In other Hyatt Hotels news, Director Cary D. Mcmillan sold 1,119 shares of the company’s stock in a transaction that occurred on Friday, May 22nd. The stock was sold at an average price of $174.96, for a total value of $195,780.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Susan D. Kronick sold 1,119 shares of the stock in a transaction that occurred on Friday, May 22nd. The shares were sold at an average price of $174.51, for a total transaction of $195,276.69. Following the completion of the sale, the director directly owned 31,225 shares of the company’s stock, valued at $5,449,074.75. This trade represents a 3.46% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 23,224 shares of company stock valued at $4,173,605. Insiders own 23.60% of the company’s stock.

Hyatt Hotels Stock Performance Shares of H stock opened at $183.52 on Friday. The company has a current ratio of 0.60, a quick ratio of 0.60 and a debt-to-equity ratio of 1.03. The company has a market cap of $17.28 billion, a PE ratio of -524.34 and a beta of 1.32. The company’s fifty day simple moving average is $188.89 and its 200-day simple moving average is $169.94. Hyatt Hotels Corporation has a 52 week low of $133.51 and a 52 week high of $206.86.

Hyatt Hotels (NYSE:H – Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.57 by $0.06. Hyatt Hotels had a positive return on equity of 6.01% and a negative net margin of 0.48%.The company had revenue of $1.75 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same period last year, the company posted $0.46 earnings per share. As a group, equities research analysts anticipate that Hyatt Hotels Corporation will post 3.58 EPS for the current year.

Analyst Upgrades and Downgrades Several research analysts have weighed in on H shares. Wells Fargo & Company boosted their price target on Hyatt Hotels from $182.00 to $186.00 and gave the company an “equal weight” rating in a report on Thursday, July 16th. Morgan Stanley lifted their price objective on Hyatt Hotels from $208.00 to $218.00 and gave the company an “overweight” rating in a research report on Friday, July 17th. Robert W. Baird upped their target price on Hyatt Hotels from $183.00 to $185.00 and gave the company a “neutral” rating in a research note on Monday, June 1st. Barclays raised their price target on Hyatt Hotels from $200.00 to $220.00 and gave the stock an “overweight” rating in a research note on Tuesday. Finally, Truist Financial lifted their price target on Hyatt Hotels from $181.00 to $187.00 and gave the company a “buy” rating in a report on Tuesday, May 26th. Nine analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $198.29.

Check Out Our Latest Stock Analysis on H

About Hyatt Hotels (Free Report)

Hyatt Hotels Corporation (NYSE: H) is a global hospitality company that develops, owns, manages and franchises luxury and business hotels, resorts and vacation properties. Its portfolio spans a range of price points and styles under brands such as Park Hyatt, Grand Hyatt, Andaz, Hyatt Regency, Hyatt Centric, Hyatt Place, Hyatt House, Thompson Hotels, Alila and Destination by Hyatt. In addition to accommodations, the company provides meeting and event spaces, food and beverage outlets, spa and wellness centers, and a variety of guest services designed to cater to both leisure and business travelers.

Hyatt’s business model combines property ownership, management contracts and third-party franchising.

Featured Articles Five stocks we like better than Hyatt Hotels Premium Retail’s Stress Test Is Separating Winners From Losers D-Wave Quantum or a Quantum ETF: Which Is the Better Bet? GE Vernova Just Sent a Mixed AI Signal to Investors Alphabet Crushed Earnings, But One Number Spooked the Market Want to see what other hedge funds are holding H? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hyatt Hotels Corporation (NYSE:H – Free Report).

Receive News & Ratings for Hyatt Hotels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyatt Hotels and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAssetmark Inc. Has $2.95 Million Position in eBay Inc. $EBAY

NEXT HEADLINE »Assetmark Inc. Purchases 9,413 Shares of Stifel Financial Corporation $SF

LOS ANGELES, July 24, 2026 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC”) (NASDAQ: CCAP) today announced it will release its financial results for the second quarter ended June 30, 2026 on Monday, August 10, 2026 after market close. Crescent BDC invites all interested persons to attend its webcast/conference call on Tuesday, August 11, 2026 at 12:00 p.m. Eastern Time to discuss its second quarter ended June 30, 2026 financial results.

Posted by Defense World Staff on Jul 24th, 2026

Fifth Third Bancorp lifted its position in Crescent Energy Company (NYSE:CRGY – Free Report) by 2,861.0% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 115,629 shares of the company’s stock after purchasing an additional 111,724 shares during the period. Fifth Third Bancorp’s holdings in Crescent Energy were worth $1,561,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in CRGY. Strs Ohio purchased a new stake in shares of Crescent Energy during the first quarter worth about $32,000. Nomura Asset Management Co. Ltd. increased its holdings in Crescent Energy by 134.5% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 3,986 shares of the company’s stock valued at $33,000 after purchasing an additional 2,286 shares during the period. Quarry LP increased its holdings in Crescent Energy by 303.5% during the 3rd quarter. Quarry LP now owns 4,152 shares of the company’s stock valued at $37,000 after purchasing an additional 3,123 shares during the period. Allworth Financial LP raised its position in Crescent Energy by 42.3% during the 4th quarter. Allworth Financial LP now owns 4,712 shares of the company’s stock valued at $40,000 after purchasing an additional 1,401 shares during the last quarter. Finally, Osaic Holdings Inc. raised its position in Crescent Energy by 25.2% during the 2nd quarter. Osaic Holdings Inc. now owns 5,301 shares of the company’s stock valued at $46,000 after purchasing an additional 1,066 shares during the last quarter. 52.11% of the stock is owned by hedge funds and other institutional investors.

Crescent Energy Price Performance Shares of CRGY opened at $11.39 on Friday. The stock has a market cap of $3.76 billion, a PE ratio of -15.19 and a beta of 1.40. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.57 and a current ratio of 0.57. Crescent Energy Company has a fifty-two week low of $7.68 and a fifty-two week high of $14.29. The firm’s 50-day simple moving average is $11.09 and its two-hundred day simple moving average is $11.18.

Crescent Energy (NYSE:CRGY – Get Free Report) last released its earnings results on Monday, May 4th. The company reported $0.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.14. The firm had revenue of $1.18 billion during the quarter, compared to analyst estimates of $1.15 billion. Crescent Energy had a negative net margin of 7.47% and a positive return on equity of 8.10%. The business’s revenue was up 24.5% on a year-over-year basis. During the same period last year, the business earned $0.57 earnings per share. Analysts anticipate that Crescent Energy Company will post 1.77 earnings per share for the current fiscal year.

Crescent Energy Dividend Announcement The business also recently announced a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Monday, May 18th were issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 4.2%. The ex-dividend date of this dividend was Monday, May 18th. Crescent Energy’s payout ratio is -64.00%.

Analysts Set New Price Targets A number of brokerages have recently weighed in on CRGY. KeyCorp reiterated an “overweight” rating and issued a $19.00 price objective on shares of Crescent Energy in a research report on Thursday, June 11th. Weiss Ratings downgraded Crescent Energy from a “hold (c)” rating to a “sell (d)” rating in a report on Wednesday, May 6th. Zacks Research lowered Crescent Energy from a “strong-buy” rating to a “hold” rating in a research note on Monday, June 29th. UBS Group assumed coverage on shares of Crescent Energy in a report on Tuesday, July 14th. They issued a “buy” rating and a $13.00 price target on the stock. Finally, Mizuho boosted their price objective on shares of Crescent Energy from $14.00 to $15.00 and gave the company a “neutral” rating in a research report on Wednesday, May 27th. Two investment analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Crescent Energy presently has an average rating of “Moderate Buy” and an average price target of $15.58.

View Our Latest Research Report on Crescent Energy

Crescent Energy Company Profile (Free Report)

Crescent Energy Co (NYSE: CRGY) is an independent exploration and production company focused on the acquisition, development and production of oil and natural gas resources in North America. Headquartered in Oklahoma City, the company’s core business activities include the identification and appraisal of prospective acreage, the design and execution of drilling and completion programs, and the ongoing operation and optimization of producing wells. Crescent Energy’s integrated approach emphasizes capital efficiency, reservoir quality and operational reliability to support sustainable cash flow generation over the commodity cycle.

Crescent Energy’s operations are concentrated in the Permian Basin, with a particular focus on the Delaware Basin’s stacked pay intervals.

Featured Articles Five stocks we like better than Crescent Energy Premium Retail’s Stress Test Is Separating Winners From Losers D-Wave Quantum or a Quantum ETF: Which Is the Better Bet? GE Vernova Just Sent a Mixed AI Signal to Investors Alphabet Crushed Earnings, But One Number Spooked the Market

Receive News & Ratings for Crescent Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Energy and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBank of Nova Scotia Buys 23,587 Shares of Franco-Nevada Corporation $FNV

NEXT HEADLINE »Bank of New York Mellon Corp Has $51.48 Million Stock Holdings in iShares MSCI ACWI ETF $ACWI

BitMEX hit with 623 BTC lawsuit on day it announces shutdown

Not financial or tax advice. PANews content is strictly educational and informational and is not investment advice, financial advice, tax advice, legal advice, or a solicitation to buy or sell any digital asset, security, or financial product. Do your own research and consult qualified advisers.

Disclosure. PANews may publish sponsored content, partner content, advertisements, affiliate links, event promotions, and market commentary involving Web3 projects, service providers, or financial products. PANews personnel, contributors, or affiliates may hold digital assets or other interests related to covered topics. See our Terms of Service.

This site is protected by reCAPTCHA.

BlackRock, Coinbase and others launch $15 million Bitcoin Quantum Defense Fund.

BlackRock, Coinbase, Strategy, Anchorage Digital, ARK Invest, Block, Blockstream, Fidelity Digital Assets, and Galaxy have formed the Bitcoin Security Consortium, pledging a combined $15 million over three years to fund Bitcoin security research and open-source development focused on quantum computing defense. The consortium does not hold or allocate funds; each member will directly select developers and researchers to support. It noted that it will not guide Bitcoin development or take positions on protocol changes. Mike Schmidt of Brink, a nonprofit developer funding organization, will coordinate the work on a volunteer basis. Currently, no quantum computer exists that can crack Bitcoin’s cryptography. Approximately 6.9 million BTC, worth $450 billion, are held in addresses that could be affected if such quantum computers emerge. Fixing this issue will require coordination among wallets, exchanges, miners, and users. Relevant efforts include proposals like BIP 360, which designs a new output type to limit public key exposure and pairs with post-quantum signature schemes. Robert Mitchnick, head of digital assets at BlackRock, stated that Core developers do important work, and the organization will provide additional funding for Bitcoin’s long-term security.

7 minutes ago

BlackRock’s Bitcoin ETF has deposited 3,126 bitcoins worth $203 million into Coinbase Prime.

According to monitoring by Onchain Lens, BlackRock’s Bitcoin ETF deposited 3,126 Bitcoin into Coinbase Prime over the past hour, valued at $203 million.

7 minutes ago

Bank of America Strategist: Market Ignoring Risks, Warn of Backlash from AI Investments

US Bank (BofA) European Equity Strategist Sebastian Raedler recently issued a stark warning: current stock market pricing logic is entirely predicated on an "everything is perfect" assumption. This extreme optimism has not only pushed market valuations to elevated levels but also left investors’ risk exposures completely unprotected. Raedler pointed out that the market’s expectations for core metrics including profit margins and five-year forward earnings growth have surged to all-time highs. In stark contrast, the "risk premium"—a gauge of market risk aversion—has dropped to a 20-year low. Raedler advised investors to decisively exit cyclical sectors with high valuations and fragile fundamentals, shifting instead to high-quality defensive stocks that have been long overlooked by the market. He specifically highlighted the healthcare and consumer staples sectors.

7 minutes ago

The EU’s 21st round of sanctions against Russia has expanded to cover 14 crypto-related platforms.

The European Union (EU) has expanded its sanctions against Russia, targeting the A7 cross-border payment network and its newly established African links, as well as the A7A5 stablecoin used for evading sanctions. The latest sanctions package extends transaction bans to 14 crypto-related platforms in countries including Georgia, the United Arab Emirates, and Panama, and introduces a tool to fully prohibit Russia from using crypto asset services. Beyond digital asset measures, the EU has imposed asset freezes and transaction bans on 94 banks and major financial institutions, and extended transaction bans to another 33 Russian credit and financial institutions.

7 minutes ago

Glassnode: Defensive positions in Bitcoin options are being unwound, and demand for bearish hedging is weakening.

Glassnode released Bitcoin options market data showing that the Bitcoin put/call open interest ratio has dropped sharply from around 0.76 at the end of June to 0.52, indicating that defensive positions are being unwound, while BTC price remains stable near $67,000. At-the-money (ATM; BlockBeats note: An at-the-money option refers to an option whose strike price is closest to the current price of the underlying asset) implied volatility remains compressed: 34.3% for 1-month tenors and 40.8% for 6-month tenors, with the term structure sloping upward, signaling that short-term event risks are being underestimated by the market. The short-term 25-delta skew has plummeted to around 4%, reflecting weakened recent demand for bearish hedging, though medium- and long-term skew still holds at a defensive premium level of 11-12%.

7 minutes ago

Whale 0x446B sells 8,010 $ETH ($15.11M) after 8 months inactivity, realizes $10.8M loss

Whale 0x446B sold 8,010 $ETH($15.11M) 2 hours ago after 8 months of inactivity, incurring a loss of $10.8M (-37%).

7 minutes ago

Key Takeaways BitMEX’s permanent closure is scheduled for September 23, 2026, concluding over a decade of operation In July 2026 alone, the platform removed 65 derivatives contracts and trading pairs from its offerings The exchange has immediately suspended new user registrations Account holders must retrieve their assets before the closure date to avoid $50 monthly charges or a 1% yearly fee The platform that introduced 100x leverage perpetual contracts gradually lost market dominance to competitors The cryptocurrency derivatives platform BitMEX, credited with creating the perpetual swap contract, will permanently cease operations on September 23, 2026. All account holders have been instructed to liquidate their positions and transfer their assets off the platform promptly.

Dear BitMEX Users,

Today, we share with a very heavy heart that BitMEX exchange will shut down its operations, effective 23 September 2026 at 04:00:00 UTC.

The owner and operator of BitMEX, HDR Global Trading Limited, has made the difficult decision to close operations… pic.twitter.com/oWuqlh547f

— BitMEX (@BitMEX) July 23, 2026

The decision to wind down operations comes after HDR Global Trading Limited, the exchange’s parent entity, conducted a comprehensive strategic assessment. The company has not disclosed detailed reasons for the closure beyond citing this internal review and current cryptocurrency market conditions.

Established in 2014 by co-founders Arthur Hayes, Ben Delo, and Samuel Reed, BitMEX once commanded the crypto derivatives landscape. The platform reached its zenith in 2019, processing more than $1 trillion in yearly trade volume and capturing approximately 57% of worldwide crypto derivatives trading.

At its height in July 2018, the platform recorded daily volumes exceeding $8 billion, with more than 1 million Bitcoin changing hands in a 24-hour period.

Accelerated Product Removals Throughout July The exchange has been swiftly reducing its available trading products. July 2026 saw the removal of 65 derivative instruments and trading pairs — a dramatic increase from only 19 delistings during the January-June period.

Platform representatives attributed these removals to “inadequate trading volume.” The accelerated timeline of product eliminations clearly demonstrates diminishing user engagement across the exchange.

Trading activity will persist for several more weeks, but August 26 marks the cutoff for initiating new positions. Any contracts still open at that time will be automatically closed ahead of the final September shutdown.

Penalties for Unclaimed Assets Account holders who fail to withdraw their holdings by the shutdown date will incur automatic charges. BitMEX will impose either a $50 monthly account maintenance charge or a 1% annual levy on dormant balances — depending on which fee structure is relevant.

According to the company’s proof of reserves documentation, all user obligations are completely backed by customer holdings. Users are advised to begin withdrawal processes early, as Bitcoin blockchain congestion may result in processing delays.

The Decline of a Market Leader The platform that pioneered the perpetual contract format gradually surrendered its market position as both established centralized competitors and emerging decentralized protocols attracted liquidity providers, professional market makers, and institutional participants.

Legal and compliance challenges contributed significantly to the platform’s decline. In 2020, authorities charged the exchange with insufficient anti-money laundering protocols, to which the company eventually entered a guilty plea. Hayes, Delo, and Reed stepped down from their positions after facing criminal prosecution from United States regulators.

This announcement arrives approximately three weeks after the departure of BitMEX’s chief executive officer, chief financial officer, and head of growth. An industry restructuring consultant informed Cointelegraph that medium-sized trading venues like BitMEX encounter systemic challenges as trading activity consolidates at major platforms while regulatory compliance expenses escalate.

Notably, throughout its 11 years of operation, BitMEX preserved an unblemished security record, never experiencing user fund losses from security breaches or smart-contract vulnerabilities.

Arthur Hayes’ BitMEX Faces Lawsuit Over Insider Trading Amid Shutdown of Operations

Crime

24 July 2026 | 13:20 BitMEX is facing a proposed class-action lawsuit alleging that its liquidation system was designed to take Bitcoin from customers and that an internal trading operation used information unavailable to ordinary users.

Key Takeaways Two customers allege that BitMEX liquidations cost them a combined 622.66 BTC. The proposed class action also claims that an internal trading desk used confidential customer information. BitMEX rejects the allegations and says it will defend the case. A similar case ended in 2025 without a ruling on the underlying liquidation claims. BKX Services Inc. and trader David Namdar filed the complaint in the US District Court for the Southern District of New York on July 23.

The plaintiffs say they lost a combined 622.66 BTC through forced liquidations. BKX claims losses of at least 305.81 BTC, while Namdar alleges that he lost more than 316.85 BTC.

The defendants include BitMEX operator HDR Global Trading Limited, several related companies, co-founders Arthur Hayes, Benjamin Delo and Samuel Reed, and former executive Gregory Dwyer.

The filing opens a civil case but does not establish that any of the allegations are true. The proposed class has not been certified, and the defendants will have an opportunity to challenge the claims.

Why the Liquidation System Is Central to the Case BitMEX became known for offering highly leveraged crypto derivatives, allowing traders to control positions much larger than the collateral deposited into their accounts.

When losses push a leveraged position beyond the exchange’s maintenance threshold, the platform can liquidate it automatically. That process is intended to prevent the account from developing a deficit that the trader cannot cover.

The plaintiffs are not arguing that exchanges have no right to liquidate undercollateralized positions. Their complaint instead claims that BitMEX closed certain trades while the remaining collateral was still worth more than the loss that needed to be covered.

According to the filing, Bitcoin left after those liquidations was transferred into the exchange’s insurance fund rather than returned to the customer. The plaintiffs allege that this arrangement gave BitMEX a financial interest in liquidating additional positions.

They are seeking the return of the Bitcoin they say was improperly retained, along with compensatory and punitive damages. The proposed class would include certain US customers who traded Bitcoin swap products on BitMEX beginning July 23, 2018.

The Complaint Alleges an Internal Trading Advantage The lawsuit also describes an operation it calls the “Insider Trading Desk.”

The plaintiffs allege that the desk could access confidential information about customer positions and liquidation levels. Such data could reveal where a relatively small price movement might trigger a larger group of forced closures.

They also claim that internal trading accounts could remain active during server outages that prevented regular customers from logging in, modifying orders or closing positions.

In this case, “insider trading” is not being used in the conventional stock-market sense of trading company shares with confidential corporate information. The complaint alleges that a proprietary desk traded on BitMEX while holding nonpublic information about other users on the same venue.

The court has not determined whether the alleged desk existed in the form described, accessed customer information or influenced liquidation events.

BitMEX Rejects the Claims BitMEX has denied the accusations.

A company spokesperson told Cointelegraph that the exchange had previously dealt with similar allegations. The spokesperson described the new filing as an opportunistic and baseless claim and said the company would vigorously defend itself.

If the case proceeds, the dispute could turn on technical records showing how the liquidation engine operated, where remaining collateral was transferred and what account permissions were available to any internal trading operation.

BitMEX may first ask the court to dismiss the complaint before the parties reach discovery. A dismissal request would test whether the plaintiffs have presented legally sufficient claims, not necessarily whether every factual allegation is correct.

An Earlier Case Ended Without Resolving Similar Claims The new complaint follows a separate proposed class action filed in 2020 by Brett Messieh, Drew Lee and other BitMEX customers.

That case also raised allegations involving forced liquidations, the exchange’s insurance fund and an internal trading desk with access to customer information.

The action was terminated on June 30, 2025. According to the final court order, the remaining plaintiff was dismissed after failing to respond to repeated instructions asking whether he intended to continue the case. The order also referred to a stipulation filed by the other parties.

The case therefore ended without a trial or a ruling on the truth of the liquidation allegations. Its closure was neither a judicial confirmation of the claims nor a finding that the disputed conduct never occurred.

The Filing Came as BitMEX Began Its Final Wind-Down The complaint was filed on the same day BitMEX announced that its exchange would close after more than 11 years of operation.

Under the official closure timetable, exchange services will end on September 23 at 04:00 UTC. The platform will become reduce-only on August 26, meaning users will no longer be able to open new positions or increase existing exposure.

BitMEX may begin closing positions during the period between those dates. Any positions still open when exchange services end will be force-closed.

Our guide to the BitMEX shutdown deadlines explains the withdrawal process, the reduce-only period and the fees that may apply to balances left on the platform.

The timing puts the lawsuit and the closure in the same news cycle, but the available information does not establish that the complaint caused the exchange to shut down. BitMEX said its board reached the decision after reviewing the business and the wider crypto industry.

BMEX and Open Interest Fell After the Closure News The market response added to the pressure surrounding the exchange.

BitMEX’s BMEX token fell more than 90% after the shutdown announcement, reaching its lowest level since trading began in November 2022. Bitcoin open interest on the exchange had also fallen from almost $3 billion at its 2024 peak to approximately $113 million.

Our analysis of the BMEX decline and contraction in BitMEX open interest shows that derivatives activity had already weakened considerably before the final closure process began.

Those market moves help explain the condition of the platform as it enters its wind-down. They do not provide evidence for or against the claims made in the lawsuit.

CZ Reflects on the Exchange’s Crypto Legacy Binance co-founder Changpeng Zhao, known as CZ, said he was “sad to see BitMEX go” and credited the exchange with helping pioneer 100x crypto perpetual contracts.

His reaction reflects BitMEX’s influence on a product that later became central to crypto derivatives trading. It did not address the new complaint or express a view on the plaintiffs’ allegations.

What Happens Next The defendants can respond to the complaint and may seek to have some or all of the claims dismissed. If the case survives that stage, the plaintiffs would still need to convince the court that their claims are suitable for treatment as a class action.

Discovery could then involve records related to the liquidation engine, the insurance fund, server outages, customer data and internal account permissions. The case could also end through dismissal, settlement or another procedural outcome before reaching trial.

For BitMEX users, the court process does not change the exchange’s operational deadlines. Traders still need to manage open positions before the platform becomes reduce-only and withdraw their assets as BitMEX moves toward its September closure.

This article is provided for informational purposes only and does not constitute financial, investment or legal advice.

Author

Alexander Zdravkov is a market analyst and crypto journalist with interests in economics, broader financial markets and digital assets. His journey into crypto began more than four years ago, driven by a fascination with the rapid evolution of blockchain technology and the transformative potential of decentralized finance. He began analyzing market cycles and identifying emerging trends before they reach the mainstream. He holds a degree in International Relations - a background that helped shape his broader perspective on global economics, geopolitics, and the interconnected nature of modern financial markets. Whether covering the latest developments in the crypto sector or exploring broader macroeconomic themes, Alexander focuses on giving readers context rather than simply repeating headlines. During his career, he has authored more than 5,000 articles covering cryptocurrencies, traditional finance, and global market developments. His work spans everything from Bitcoin and altcoins to macroeconomic trends influencing risk assets worldwide.

BitMEX faces 623 BTC lawsuit as exchange confirms September 23 shutdown

THE BLOCK: Arthur Hayes, BitMEX co-founders face fraud claims over alleged 'Insider Trading Desk' as exchange winds down

Posted by Defense World Staff on Jul 24th, 2026

California Public Employees Retirement System raised its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 21.9% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 253,479 shares of the company’s stock after acquiring an additional 45,596 shares during the period. California Public Employees Retirement System owned 0.13% of BridgeBio Pharma worth $18,823,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Global Retirement Partners LLC grew its position in shares of BridgeBio Pharma by 271.5% in the fourth quarter. Global Retirement Partners LLC now owns 509 shares of the company’s stock valued at $39,000 after purchasing an additional 372 shares during the period. Farther Finance Advisors LLC lifted its position in BridgeBio Pharma by 91.4% during the fourth quarter. Farther Finance Advisors LLC now owns 513 shares of the company’s stock worth $39,000 after buying an additional 245 shares during the period. Kemnay Advisory Services Inc. purchased a new position in BridgeBio Pharma during the fourth quarter worth about $41,000. Cary Street Partners Investment Advisory LLC boosted its stake in BridgeBio Pharma by 861.0% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 567 shares of the company’s stock worth $43,000 after buying an additional 508 shares during the last quarter. Finally, Eurizon Capital SGR S.p.A. acquired a new stake in BridgeBio Pharma in the 4th quarter worth about $44,000. Hedge funds and other institutional investors own 99.85% of the company’s stock.

Insider Activity In related news, CEO Neil Kumar sold 40,000 shares of BridgeBio Pharma stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $67.46, for a total transaction of $2,698,400.00. Following the transaction, the chief executive officer owned 535,686 shares in the company, valued at approximately $36,137,377.56. The trade was a 6.95% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Thomas Trimarchi sold 13,651 shares of the company’s stock in a transaction dated Monday, May 18th. The stock was sold at an average price of $65.08, for a total value of $888,407.08. Following the completion of the sale, the chief financial officer directly owned 359,194 shares of the company’s stock, valued at $23,376,345.52. The trade was a 3.66% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 432,117 shares of company stock valued at $32,633,740 over the last quarter. 14.23% of the stock is owned by insiders.

BridgeBio Pharma Price Performance Shares of NASDAQ:BBIO opened at $82.93 on Friday. The business has a 50-day moving average of $72.33 and a two-hundred day moving average of $72.45. The firm has a market capitalization of $16.24 billion, a PE ratio of -22.17 and a beta of 0.95. BridgeBio Pharma, Inc. has a 12 month low of $42.09 and a 12 month high of $93.42.

BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The company reported ($0.84) earnings per share for the quarter, missing the consensus estimate of ($0.70) by ($0.14). The firm had revenue of $194.51 million during the quarter, compared to analyst estimates of $178.07 million. BridgeBio Pharma’s quarterly revenue was up 66.8% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.88) earnings per share. As a group, research analysts anticipate that BridgeBio Pharma, Inc. will post -2.29 earnings per share for the current year.

Analyst Ratings Changes Several analysts have commented on BBIO shares. HC Wainwright lifted their price target on BridgeBio Pharma from $110.00 to $120.00 and gave the company a “buy” rating in a report on Monday, July 13th. Weiss Ratings reissued a “sell (d)” rating on shares of BridgeBio Pharma in a research report on Friday, May 15th. Royal Bank Of Canada assumed coverage on shares of BridgeBio Pharma in a research report on Thursday, April 9th. They issued an “outperform” rating and a $100.00 target price on the stock. Canaccord Genuity Group assumed coverage on shares of BridgeBio Pharma in a report on Wednesday, June 3rd. They issued a “buy” rating and a $104.00 target price for the company. Finally, Truist Financial upped their price target on shares of BridgeBio Pharma from $95.00 to $102.00 and gave the stock a “buy” rating in a research report on Wednesday, April 29th. Twenty analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $95.21.

View Our Latest Report on BridgeBio Pharma

BridgeBio Pharma Profile (Free Report)

BridgeBio Pharma, Inc is a clinical-stage biopharmaceutical company headquartered in Palo Alto, California. Founded in 2015 by Neil Kumar, the company is dedicated to discovering, developing and delivering transformative medicines for patients with genetic diseases and cancers. BridgeBio operates an integrated model that spans target identification, preclinical research, clinical development and commercialization, aiming to streamline the process from bench to bedside.

BridgeBio’s pipeline comprises multiple therapeutic modalities, including small molecules, biologics and genetic therapies.

Further Reading Five stocks we like better than BridgeBio Pharma Premium Retail’s Stress Test Is Separating Winners From Losers D-Wave Quantum or a Quantum ETF: Which Is the Better Bet? GE Vernova Just Sent a Mixed AI Signal to Investors Alphabet Crushed Earnings, But One Number Spooked the Market

Receive News & Ratings for BridgeBio Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BridgeBio Pharma and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINECalifornia Public Employees Retirement System Raises Stake in Autoliv, Inc. $ALV

NEXT HEADLINE »Toast, Inc. $TOST Shares Sold by California Public Employees Retirement System

769 Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.